ClinicalTrials.Veeva

Menu

Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes (RINCAL)

B

Brighton and Sussex University Hospitals NHS Trust

Status

Completed

Conditions

Acute Coronary Syndromes

Treatments

Drug: Conservative Arm
Procedure: Invasive Arm

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02086019
BN-AdB-RINCAL-2013

Details and patient eligibility

About

For octogenarian patients with NSTEMI (non-ST segment elevation myocardial infarction) an invasive-guided strategy will prove superior to a conservative strategy with respect to a combined endpoint of all cause mortality and non-fatal myocardial infarction.

Enrollment

250 patients

Sex

All

Ages

80+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • AGE>80 Non-STEMI - characteristic chest pain accompanied by
  • Typical ischaemic ECG changes
  • A troponin rise

Suitable for conservative or invasive strategy

Exclusion criteria

  • Lack of suitability for whatever clinical reason to be randomised eg dementia, co-morbidity
  • Acute STEMI
  • Cardiogenic shock
  • Platelet count =50 x 109/mm3
  • Patient life expectancy < 1 year
  • Known allergies to clopidogrel, aspirin, heparin, stainless steel, IV contrast or stent drug elutant
  • Recent major GI haemorrhage (within 3 months)
  • Any previous cerebral bleeding episode
  • Participation in another investigational drug or device study
  • Patient unable to give consent
  • Clinical decision precluding the use of stents

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

250 participants in 2 patient groups

Conservative Arm- Medical therapy
Other group
Description:
Medical therapy
Treatment:
Drug: Conservative Arm
Invasive Arm-angiogram with PCI or CABG
Other group
Description:
same medical drug therapy as conservative arm, and angiogram with PCI (percutaneous coronary intervention) or CABG (coronary artery bypass grafting) revascularisation if appropriate
Treatment:
Procedure: Invasive Arm

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems